writing effective introductions and abstracts
DESCRIPTION
Session Three of Scientific Writing SeriesTRANSCRIPT
![Page 1: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/1.jpg)
Office of Clinical Research
Writing Effective Writing Effective Introductions and AbstractsIntroductions and Abstracts
Presented by:Presented by:
Wayne Loftus, MLS, Bio-Medical LibraryWayne Loftus, MLS, Bio-Medical LibraryMary Knatterud, PhD, Department of SurgeryMary Knatterud, PhD, Department of Surgery
April 27, 2007April 27, 2007
![Page 2: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/2.jpg)
Office of Clinical Research
Brenda Hudson Disclosure InformationBrenda Hudson Disclosure InformationApril 27, 2007April 27, 2007
• I will not discuss off label use I will not discuss off label use and/or investigational use in my and/or investigational use in my presentation.presentation.
• I have no financial relationships to I have no financial relationships to disclose.disclose.
![Page 3: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/3.jpg)
Office of Clinical Research
AgendaAgenda
• Key termsKey termsWayne LoftusWayne Loftus
• OverviewOverviewMary KnatterudMary Knatterud
• Hands-on exerciseHands-on exerciseMary KnatterudMary Knatterud
• Q&AQ&A
![Page 4: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/4.jpg)
Office of Clinical Research
Wayne Loftus Disclosure InformationWayne Loftus Disclosure InformationApril 27, 2007April 27, 2007
• I will not discuss off label use I will not discuss off label use and/or investigational use in my and/or investigational use in my presentation.presentation.
• I have no financial relationships to I have no financial relationships to disclose.disclose.
![Page 5: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/5.jpg)
Information that’s hard to find willInformation that’s hard to find willremain information that’s hardly remain information that’s hardly
found.found.
- Peter Morville- Peter Morville
![Page 6: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/6.jpg)
find·a·bil·i·ty n
a. The quality of being locatable or navigable.
c. The degree to which a system or environment supports navigation and retrieval.
b. The degree to which a particular object is easy to discover or locate.
![Page 7: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/7.jpg)
![Page 8: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/8.jpg)
![Page 9: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/9.jpg)
Office of Clinical Research
Mary Knatterud Disclosure Information Disclosure InformationApril 27, 2007April 27, 2007
• I will not discuss off label use I will not discuss off label use and/or investigational use in my and/or investigational use in my presentation.presentation.
• I have no financial relationships to I have no financial relationships to disclose.disclose.
![Page 10: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/10.jpg)
Office of Clinical Research
Mary Knatterud Disclosure Information Disclosure InformationApril 27, 2007April 27, 2007
• I will not discuss off label use I will not discuss off label use and/or investigational use in my and/or investigational use in my presentation.presentation.
• I have no financial relationships to I have no financial relationships to disclose.disclose.
![Page 11: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/11.jpg)
Office of Clinical Research
Mary Knatterud Disclosure Information Disclosure InformationApril 27, 2007April 27, 2007
• I will not discuss off label use I will not discuss off label use and/or investigational use in my and/or investigational use in my presentation.presentation.
• I have no financial relationships to I have no financial relationships to disclose.disclose.
![Page 12: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/12.jpg)
Office of Clinical Research
Mary Knatterud Disclosure Information Disclosure InformationApril 27, 2007April 27, 2007
• I will not discuss off label use I will not discuss off label use and/or investigational use in my and/or investigational use in my presentation.presentation.
• I have no financial relationships to I have no financial relationships to disclose.disclose.
![Page 13: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/13.jpg)
Office of Clinical Research
Mary Knatterud Disclosure Information Disclosure InformationApril 27, 2007April 27, 2007
• I will not discuss off label use I will not discuss off label use and/or investigational use in my and/or investigational use in my presentation.presentation.
• I have no financial relationships to I have no financial relationships to disclose.disclose.
![Page 14: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/14.jpg)
Office of Clinical Research
Mary Knatterud Disclosure InformationMary Knatterud Disclosure InformationApril 27, 2007April 27, 2007
• I will not discuss off label use I will not discuss off label use and/or investigational use in my and/or investigational use in my presentation.presentation.
• I have no financial relationships to I have no financial relationships to disclose.disclose.
![Page 15: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/15.jpg)
Office of Clinical Research
AbstractAbstract
Useful format: Useful format:
• BackgroundBackground
• MethodsMethods
• ResultsResults
• ConclusionsConclusions
![Page 16: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/16.jpg)
Office of Clinical Research
AbstractAbstractUse active voiceUse active voice
End background section with End background section with hypothesishypothesis
Cover the high points of your resultsCover the high points of your results
Conclude with 1 or 2 sentencesConclude with 1 or 2 sentences
![Page 17: Writing Effective Introductions and Abstracts](https://reader035.vdocument.in/reader035/viewer/2022070322/559280ad1a28ab33678b458f/html5/thumbnails/17.jpg)
Office of Clinical Research
IntroductionIntroduction
Three Paragraphs:Three Paragraphs:
11stst: state the general problem: state the general problem22ndnd: outline the specific problem: outline the specific problem33rdrd: state the type of study it was and : state the type of study it was and the hypothesisthe hypothesis